Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.35 | 3e-28 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.34 | 9e-23 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.33 | 5e-22 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.36 | 2e-15 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-15 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-13 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-11 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.27 | 2e-09 |